Bone Density Screening: Why Waiting Until 65 Is Often Too Late
Current U.S. guidelines recommend routine DEXA screening starting at age 65 for women — or earlier only if a woman is deemed “high risk.”
DEXA (dual-energy X-ray absorptiometry) screening measures bone mineral density (BMD) to diagnose osteoporosis and predict fracture risk, with T-scores guiding intervention. Guidelines recommend it for all women at the age of 65.
In practice, this approach often misses the window where prevention is most powerful.
The most rapid bone loss in a woman’s lifetime typically occurs during the perimenopause and early postmenopause years, when estrogen levels fluctuate and then decline. By the time a woman reaches 65, meaningful bone loss may already be established — sometimes irreversible, emphasizing proactive assessment via tools like FRAX.
From a preventive medicine standpoint, earlier screening allows us to:
Identify accelerated bone loss before fracture risk escalates
Intervene with lifestyle, nutrition, resistance training, and hormone optimization sooner
Track individual bone trajectory over time rather than reacting late
Personalize hormone and non-hormonal prevention strategies
The encouraging news: insurance often covers earlier DEXA scans when appropriate risk factors are documented.
Risk Factors That Support Earlier DEXA Screening Coverage
Many insurers recognize the following clinical risk factors as justification for bone density screening before age 65. These are commonly used in medical necessity documentation and align with USPSTF, NOF, AACE, and insurer medical policy language.
Hormonal & Reproductive Factors
Early menopause (before age 45)
Premature ovarian insufficiency (before age 40)
Surgical menopause (oophorectomy ± hysterectomy)
Prolonged hypoestrogenic states (amenorrhea, eating disorders, overtraining)
Long-term use or discontinuation of hormone suppression therapies
Personal & Family History
Personal history of low-trauma (fragility) fracture after age 40
Parental history of hip fracture or severe osteoporosis
Small body frame or low BMI (<20–21)
Medication Exposure
Chronic glucocorticoid use (≥3 months of prednisone ≥5 mg/day or equivalent)
Aromatase inhibitors (breast cancer treatment)
GnRH agonists or anti-estrogen therapies
Long-term proton pump inhibitor use
Certain anticonvulsants
Excess thyroid hormone replacement
Medical Conditions Associated with Bone Loss
Autoimmune or inflammatory disease (RA, lupus, IBD)
Thyroid disease (especially hyperthyroidism or over-replacement)
Malabsorption syndromes (celiac disease, bariatric surgery)
Chronic kidney disease
Diabetes (especially type 1 or long-standing type 2)
Eating disorders or chronic undernutrition
Lifestyle & Nutritional Factors
Low dietary calcium or vitamin D deficiency
Sedentary lifestyle or low muscle mass
Smoking history
Excess alcohol intake
High fall risk or balance impairment
Clinical Red Flags
Height loss ≥1–1.5 inches
Chronic back pain or kyphosis
Radiographic evidence of vertebral compression
Elevated fracture risk on FRAX calculation
When these factors are clearly documented, early screening is frequently covered — even in women in their 40s and 50s.
Are There Downsides to DEXA Screening?
One of the most common questions I hear is whether bone density screening carries meaningful risks — particularly related to radiation exposure or psychological harm.
The reassuring answer is: the downsides are minimal.
According to a review cited by Sfeir (2020), the U.S. Preventive Services Task Force (USPSTF) found no significant harms associated with DXA screening. Specifically, screening was not associated with increased anxiety, reduced quality of life, or adverse psychological effects related to testing or diagnosis.
From a radiation standpoint, DXA uses extremely low radiation exposure. A typical scan delivers approximately 0.001 mSv — roughly equivalent to about three hours of natural background radiation from everyday living.
For comparison:
A mammogram exposes a patient to approximately 0.4 mSv of radiation — hundreds of times higher than a DXA scan.
Even with repeat testing over time, cumulative DXA radiation remains clinically negligible.
In other words, the safety profile of DXA is exceptionally favorable, especially when weighed against the consequences of undetected bone loss and fracture risk.
For women who meet risk criteria, early screening offers far more potential benefit than downside.
My Clinical Perspective
Guidelines are designed for population safety and cost containment — not individualized longevity medicine.
In real-world practice, I routinely see motivated, healthy women in their 40s and early 50s who are already losing bone rapidly — often without symptoms, fractures, or obvious risk flags until we look deeper.
Earlier screening allows us to:
Establish a baseline during the hormonal transition
Identify silent osteopenia before fragility develops
Optimize hormone timing rather than reacting late
Preserve long-term mobility and independence
Bone loss is far easier to prevent than to reverse.
If you’re navigating perimenopause, menopause, or have any of the above risk factors, a conversation about early bone density screening is not only reasonable — it’s smart medicine.
Reference
American Academy of Family Physicians. (2023, March 1). Osteoporosis: Common questions and answers. https://www.aafp.org/pubs/afp/issues/2023/0300/osteoporosis.pdf
Courie Center. (2021, May 6). Courigirl FACT: Risk factors for a DEXA scan before age 65. https://www.couricenter.com/articles/courigirl-fact-risk-factors-for-a-dexa-scan-before-age-65/
Mohammad, A., et al. (2022, August 5). A novel osteoporosis screening protocol to identify orthopedic surgery patients at high risk for fragility fracture. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9364193/
Sfeir, J. G., et al. (2020, April). To scan or not to scan? DXA in postmenopausal women. Cleveland Clinic Journal of Medicine, 87(4), 205–213. https://www.ccjm.org/content/87/4/205
U.S. Preventive Services Task Force. (2025, January 13). Osteoporosis to prevent fractures: Screening. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
U.S. Preventive Services Task Force. (2025, February 10). Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. JAMA. https://jamanetwork.com/journals/jama/fullarticle/2829238